Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis

Respiratory Research

Volumn 12, Issue , 2011, Pages

  Di Paola, Rosanna ^a   Talero, Elena ^c   Galuppo, Maria ^b   Mazzon, Emanuela ^a   Bramanti, Placido ^a   Motilva, Virginia ^c   Cuzzocrea, Salvatore ^a,b  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ADRENOMEDULLIN; BLEOMYCIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MYELOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PADGEM PROTEIN; TRANSFORMING GROWTH FACTOR BETA; 3-NITROTYROSINE; ANTIINFLAMMATORY AGENT; AUTACOID; CELL ADHESION MOLECULE; CYTOKINE; DRUG DERIVATIVE; NOS2 PROTEIN, MOUSE; PEROXIDASE; TYROSINE;

ARTICLE; BODY WEIGHT; DENSITOMETRY; ENZYME ACTIVITY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; LUNG INJURY; PROTEIN EXPRESSION; SHAM PROCEDURE; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; HOSPITALIZATION; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG; MALE; METABOLISM; MOUSE; PATHOLOGY; PNEUMONIA; TIME;

ADRENOMEDULLIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLEOMYCIN; CELL ADHESION MOLECULES; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; INJECTIONS, INTRAPERITONEAL; LUNG; MALE; MICE; MICE, INBRED ICR; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; PNEUMONIA; POLY(ADP-RIBOSE) POLYMERASES; PULMONARY FIBROSIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TYROSINE;

EID: 79953733330     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-41     Document Type: Article

References (35)

1. Kim DS, Collard HR, King TE. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006, 3(4):285-292.
2. Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease?. Proc Am Thorac Soc 2006, 3(4):293-298.
3. Kawut SM, O'Shea MK, Bartels MN, Wilt JS, Sonett JR, Arcasoy SM. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med 2005, 99(11):1431-1439.
4. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008, 214(2):199-210.
5. Sanchez O, Marcos E, Perros F, Fadel E, Tu L, Humbert M, Dartevelle P, Simonneau G, Adnot S, Eddahibi S. Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2007, 176(10):1041-1047.
6. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nature Rev 2004, 4(8):583-594.
7. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993, 192(2):553-560.
8. Shimosawa T, Fujita T. Adrenomedullin and its related peptide. Endocrine J 2005, 52(1):1-10.
9. Albertin G, Ruggero M, Guidolin D, Nussdorfer GG. Gene silencing of human RAMP2 mediated by short-interfering RNA. Int J Mol Med 2006, 18(4):531-535.
10. Garcia MA, Martin-Santamaria S, de Pascual-Teresa B, Ramos A, Julian M, Martinez A. Adrenomedullin: a new and promising target for drug discovery. Expert Opin Ther Targets 2006, 10(2):303-317.
11. Zudaire E, Portal-Nunez S, Cuttitta F. The central role of adrenomedullin in host defense. J Leukocyte Biol 2006, 80(2):237-244.
12. Christ-Crain M, Morgenthaler NG, Stolz D, Muller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Muller B. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit care (London, England) 2006, 10(3):R96.
13. Li YY, Wong LY, Cheung BM, Hwang IS, Tang F. Differential induction of adrenomedullin, interleukins and tumour necrosis factor-alpha by lipopolysaccharide in rat tissues in vivo. Clin Exp Pharm Physiol 2005, 32(12):1110-1118.
14. Zhou M, Chaudry IH, Wang P. The small intestine is an important source of adrenomedullin release during polymicrobial sepsis. Am J Physiol 2001, 281(2):R654-660.
15. Cheung BM, Hwang IS, Li CY, O WS, Tsang KW, Leung RY, Kumana CR, Tang F. Increased adrenomedullin expression in lungs in endotoxaemia. J Endocrinol 2004, 181(2):339-345.
16. Agorreta J, Zulueta JJ, Montuenga LM, Garayoa M. Adrenomedullin expression in a rat model of acute lung injury induced by hypoxia and LPS. Am J Physiol Lung Cell Mol Physiol 2005, 288(3):L536-545.
17. Talero E, Sanchez-Fidalgo S, de la Lastra CA, Illanes M, Calvo JR, Motilva V. Acute and chronic responses associated with adrenomedullin administration in experimental colitis. Peptides 2008, 29(11):2001-2012.
18. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988, 41(4):467-470.
19. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985, 14(3):157-167.
20. Elsasser TH, Kahl S. Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response. Microsc Res Techniq 2002, 57(2):120-129.
21. Jougasaki M, Burnett JC. Adrenomedullin: potential in physiology and pathophysiology. Life Sci 2000, 66(10):855-872.
22. Smith RE, Strieter RM, Zhang K, Phan SH, Standiford TJ, Lukacs NW, Kunkel SL. A role for C-C chemokines in fibrotic lung disease. J Leukocyte Biol 1995, 57(5):782-787.
23. von der Hardt K, Kandler MA, Popp K, Schoof E, Chada M, Rascher W, Dotsch J. Aerosolized adrenomedullin suppresses pulmonary transforming growth factor-beta1 and interleukin-1 beta gene expression in vivo. Eur J Pharmacol 2002, 457(1):71-76.
24. Mautino G, Oliver N, Chanez P, Bousquet J, Capony F. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 1997, 17(5):583-591.
25. Vanhee D, Delneste Y, Lassalle P, Gosset P, Joseph M, Tonnel AB. Modulation of endothelial cell adhesion molecule expression in a situation of chronic inflammatory stimulation. Cell Immunol 1994, 155(2):446-456.
26. Hamaguchi Y, Nishizawa Y, Yasui M, Hasegawa M, Kaburagi Y, Komura K, Nagaoka T, Saito E, Shimada Y, Takehara K, et al. Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis. Am J Pathol 2002, 161(5):1607-1618.
27. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004, 84(3):731-765.
28. Caramori G, Papi A. Oxidants and asthma. Thorax 2004, 59(2):170-173.
29. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996, 9(5):836-844.
30. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998, 391(6665):393-397.
31. Virag L. Poly(ADP-ribosyl)ation in asthma and other lung diseases. Pharm Res 2005, 52(1):83-92.
32. Fine A, Goldstein RH. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem 1987, 262(8):3897-3902.
33. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987, 105(3):1039-1045.
34. Hoyt DG, Lazo JS. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther 1988, 246(2):765-771.
35. Khalil N, Corne S, Whitman C, Yacyshyn H. Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 1996, 15(2):252-259.